特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
238169

幹細胞研究製品:市場機会・ツール・技術 (2020年)

Stem Cell Research Products - Opportunities, Tools & Technologies (2020)

出版日: | 発行: BIOINFORMANT WORLDWIDE, LLC | ページ情報: 英文 251 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.80円
幹細胞研究製品:市場機会・ツール・技術 (2020年)
出版日: 2020年01月06日
発行: BIOINFORMANT WORLDWIDE, LLC
ページ情報: 英文 251 Pages
納期: 即納可能 即納可能とは
担当者のコメント
幹細胞関連の論文発行件数や研究者へのアンケート調査等、様々な情報を基に研究関連製品への需要量を推定したレポートです
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、幹細胞研究に用いられる各種製品の市場を調査し、幹細胞研究の概要、製品の分類、各製品の概要、製品区分・詳細タイプ別の5カ年予測、競合環境、企業シェア、主要企業のプロファイルなどをまとめています。

第1章 レポート概要

第2章 幹細胞研究:イントロダクション

第3章 幹細胞マーカー

  • 胚性幹細胞 (ESC) マーカー
  • 造血幹細胞マーカー
  • 癌幹細胞マーカー
  • 骨前駆細胞マーカー
  • 神経幹細胞 マーカー
  • 間葉系幹細胞マーカー
  • 皮膚幹細胞マーカー

第4章 幹細胞単離製品

  • 幹細胞単離におけるフローサイトメトリー
  • フローサイトメトリーシステム

第5章 抗体

  • 原発性抗体
  • 二次抗体
  • 組換え抗体
  • 治験用抗体
  • アポトーシス抗体
  • エピトープタグ・融合タンパク質抗体
  • アイソタイプコントロール抗体
  • 幹細胞マーカー抗体
  • 多能性幹細胞マーカー抗体製品
  • 間葉系幹細胞マーカー抗体製品
  • 造血幹細胞マーカー抗体製品
  • 神経幹細胞マーカー抗体
  • 癌幹細胞マーカー抗体
  • 抗体製造
  • SCF ELISAキット

第6章 幹細胞培地

  • 培地タイプ
  • 主な培地
  • 幹細胞培地
  • 胚性幹細胞培地
  • 造血幹細胞培地
  • 間葉系幹細胞培地
  • 神経幹細胞培地、など

第7章 バイオリアクター

  • ステンレス鋼定置型バイオリアクター
  • 単回使用バイオリアクター

第8章 幹細胞株

  • 幹細胞株の利用
  • 幹細胞株のタイプ
  • 上市済み幹細胞株

第9章 幹細胞製造

  • 研究機関による幹細胞製造
  • 商業製造への移行
  • CMO
  • 幹細胞製造プロセス

第10章 幹細胞製造コスト

第11章 幹細胞研究製品:市場分析

  • 世界の細胞培養研究用フローサイトメトリーシステム市場
    • 企業シェア
  • 世界の幹細胞研究抗体市場
    • 企業シェア
  • 幹細胞アッセイ製品市場
    • 製品区分別
  • 世界の幹細胞培地市場
    • 企業シェア
  • 世界の組換え細胞培養サプリメント市場
  • 世界の幹細胞凍結保存製品市場
    • 製品タイプ別シェア
  • 幹細胞培養向け単回使用バイオリアクター市場
    • 製品区分別
    • 企業シェア
  • 単回使用バイオリアクターへの大型投資
  • 世界の細胞培養向けマイクロキャリア市場
  • 人工多能性幹細胞市場
  • ヒト間葉系幹細胞 (hMSCs) 市場
  • 世界の胚性幹細胞市場
  • 世界の幹細胞市場
  • 世界の幹細胞研究用製品市場

第12章 企業プロファイル

目次

Featuring newly released market size data with detailed segmentation and 5-year projections (2020-2024).

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Several broad categories of stem cells exist, including:

  • Embryonic stem cells, derived from blastocysts
  • Perinatal stem cells, obtained during the period immediately before and after birth
  • Adult stem cells, found in adult tissues
  • Induced pluripotent stem cells, produced by genetically reprogramming adults cells
  • Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body

Stem cell research and experimentation have been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

The possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to cell therapy, tissue regeneration, bioprinting, drug discovery, toxicology testing, and more. Of interest to clinical researchers is the potential to use stem cells within regenerative medicine, and the pharmaceutical industry is integrating stem cells to conduct pharmacological testing on cell-specific tissues. There is also demand for extracellular vesicles (EVs) derived from stem cells, because they can act as intercellular messengers and may be able to exert some types of therapeutic effects.

Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral, and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which results in fewer options for use. Thus, when induced pluripotent stem cells (iPSCs) were discovered in 2006 by Shinya Yamanaka of Kyoto University in Japan, they represented a promising combination of adult and embryonic stem cell characteristics.

iPSCs are adult cells which are isolated and then transformed into embryonic-like stem cells through the manipulation of gene expression and other methods. The first successful generation of iPSCs was via research and experimentation using mouse cells at Kyoto University in Japan. In 2007, a series of follow-up experiments were done at Kyoto University in which human adult cells were transformed into iPSC cells. Nearly simultaneously, a research group led by James Thomson at the University of Wisconsin-Madison accomplished the same feat of deriving iPSC lines from human somatic cells.

To facilitate research resulting from interest in these far-ranging applications, a large and rapidly growing market for stem cells research products has emerged. Today, well over one-hundred companies produce products to support the activities of stem cell scientists worldwide. The tools commercialized by these companies include ones to isolate, expand, culture, differentiate, and characterize stem cells, as well as technologies to enable their production at any scale.

Broad categories of stem cell research products include, but are not limited to:

  • Stem cell lines (such as iPSCs, MSCs, HSCs, NSCs, and ESCs)
  • Stem cell culture media with supplements
  • Consumables (such as antibodies, consumables in assays, cryoprotective agents and microcarriers)
  • Instruments (such as freezers, bioreactors, cytometry devices, and assay systems)
  • Stem cell services

Specifically, the following compose the majority of stem cell product sales:

  • Primary antibodies to stem cell antigens
  • Bead-based stem cell separation systems
  • Fluorescent-based labeling and detection
  • Stem cell protein purification and analysis tools
  • Tools for DNA and RNA-based characterization of stem cells
  • Isolation/characterization services
  • Stem cell culture media and reagents
  • Stem cell specific growth factors and cytokines
  • Tools for stem cell gene regulation
  • Mechanisms for in vivo and in vitro stem cell tracking
  • Expansion/differentiation services for stem cell media and RNAi
  • Stem cell lines
  • Done-for-you or done-with-you services

With market competition growing increasingly fierce, ten of the largest companies selling stem cell research products are:

  • Thermo Fisher Scientific
  • BD Biosciences, a Division of Becton Dickinson (BD)
  • Merck KGaA
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Lonza Group
  • Takara Bio
  • GE Healthcare Life Sciences
  • FUJIFILM CDI
  • Sigma Aldrich

Furthermore there are many specialty vendors of stem cell research products, such as FUJIFILM CDI, ReproCELL and Ncardia (who specialize in iPSC-related products), RoosterBio (who specializes in human MSC-specific products), and Corning (who specializes in Matrigel® products to support pluripotent stem cell culture and cultureware), for example.

Key report findings include:

  • Stem cell research applications, including priorities by segment
  • Relative demand for stem cell products, by stem cell type
  • Analysis of stem cell manufacturing technologies, including costs, risks, and the rise of contact manufacturing organizations (CMOs)
  • Analysis of market trends, including opportunities and threats
  • Competitive analysis for 128 market participants composing the global market
  • Market size determination, including detailed segmentation and 5-year projections (2019-2024)

Input Sources

The content and statistics contained in this report were compiled using a broad range of sources. These input sources include:

  • Interviews with Stem Cell Executives, completed by BioInformant's Founder and Analysts
  • Stem Cell Grant Funding Database (RePORT Database, CIRM, MRC, Wellcome Trust - UK)
  • Stem Cell Patent Database (United States Patent and Trade Office, World Intellectual Property Organization)
  • Stem Cell Clinical Trial Database (ClinicalTrials.gov, International Clinical Trials Registry Platform, European Union Clinical Trials Register)
  • Stem Cell Scientific Publication Database (PubMed, Highwire Press, Google Scholar)
  • Stem Cell Product Launch Announcements (Trade Journals, Google News)
  • Stem Cell Industry Events (Google News, Google Alerts)
  • Stem Cell Company News (SEC Filings, Investor Publications, Historic Performance)
  • Social Analytics Platforms (Google Trends, Google Adwords, BuzzSumo, Hashtagify.me)
  • And More

The possibilities arising from stem cells have resulted in great commercial interest. Use this report to identify emerging market opportunities, spot new product development opportunities before your competition, and make smarter decisions, faster.

TABLE OF CONTENTS

1. REPORT OVERVIEW

  • 1.1. Statement of the Report
  • 1.2. Executive Summary

2. STEM CELL RESEARCH: AN INTRODUCTION

  • 2.1. Identification of Stem Cells
  • 2.2. Species Sources of Stem Cells for Research
  • 2.3. Culturing Stem Cell Lines
  • 2.4. Differentiation of Stem Cells
  • 2.5. Benefits of Stem Cell Research
    • 2.5.1. Basic Research
    • 2.5.2. Stem Cells in Drug Discovery
    • 2.5.3. Disease Modeling
    • 2.5.4. Stem Cells in Toxicity Screening

3. STEM CELLS MARKERS

  • 3.1. Embryonic Stem Cell (ESC) Markers
  • 3.2. Hematopoietic Stem Cell Markers
  • 3.3. Cancer Stem Cell Markers
  • 3.4. Osteoprogenitor Cell Markers
  • 3.5. Neural Stem Cell Markers
  • 3.6. Mesenchymal Stem Cell Markers
  • 3.7. Skin Stem Cell Markers

4. STEM CELL ISOLATION PRODUCTS

  • 4.1. Flow Cytometry in Stem Cell Isolation
  • 4.2. Flow Cyometry Systems

5. ANTIBODIES

  • 5.1. Primary Antibodies
  • 5.2. Secondary Antibodies
  • 5.3. Recombinant Antibodies
  • 5.4. Trial Size Antibodies
  • 5.5. Apoptosis Antibodies
  • 5.6. Epitope Tag and Fusion Protein Antibodies
  • 5.7. Isotype CONTrol Antibodies
  • 5.8. Stem Cell Marker Antibodies
  • 5.9. Pluripotent Stem Cell Markers Antibody Products
  • 5.10. Mesenchymal Stem Cell Markers Antibody Products
  • 5.11. Hematopoietic Stem Cell Markers Antibody Products
  • 5.12. Neural Stem Cell Marker Antibodies
  • 5.13. Cancer Stem Cell Marker Antibodies
  • 5.14. Antibody Production
    • 5.14.1. Antibody Production and Development Services
    • 5.14.2. Monoclonal Antibody Production Services
    • 5.14.3. Polyclonal Antibody Production Services
    • 5.14.4. Antibody Purification Services
    • 5.14.5. Antibody Conjugation and Labeling Services
    • 5.14.6. Hybridoma Services
    • 5.14.7. Recombinant Antibody Production Services
  • 5.15. Stem Cell Factor ELISA Kits

6. STEM CELL CULTURE MEDIA

  • 6.1. Types of Culture Media
  • 6.2. Choice of Cell Culture Media
    • 6.2.1. Recommended Media for Primary Cell Culture
  • 6.3. Stem Cell Culture Media
    • 6.3.1. Methylcellulose Media
    • 6.3.2. Differentiation Media
    • 6.3.3. Expansion Media
  • 6.4. Embryonic Stem Cell Media
  • 6.5. Hematopoietic Stem Cell Media
  • 6.6. Mesenchymal Stem Cell Media
  • 6.7. Neural Stem Cell Media
  • 6.8. Media Supplements for Stem Cell Culture
  • 6.9. Cell Storage Media

7. BIOREACTORS

  • 7.1. Stainless Steel Fixed Bioreactors
  • 7.2. Single-Use Bioreactors
    • 7.2.1. Single-Use System Types
    • 7.2.2. Main Features of Commercial Bioreactors
    • 7.2.3. Main Differences between Single-Use and Multi-Use Bioreactors
    • 7.2.4. Microcarriers used in Bioreactors

8. STEM CELL LINES

  • 8.1. Use of Stem Cell Lines
  • 8.2. Types of Stem Cell Lines
    • 8.2.1. Embryonic Stem Cell Lines (ESC Line)
    • 8.2.2. Adult Stem Cell Lines
    • 8.2.3. Induced Pluripotent Stem Cell Lines (iPSC Lines)
  • 8.3. Commercially Available Stem Cell Lines

9. STEM CELL MANUFACTURING

  • 9.1. Institutional Manufacturing of Stem Cells
  • 9.2. Transition to Commercial Manufacturing of Stem Cells
  • 9.3. CMOs Involved with Stem Cell Manufacturing
  • 9.4. Stem Cell Manufacturing Process
    • 9.4.1. Scale-Up Methods
    • 9.4.2. Closed Automated Systems

10. COST OF STEM CELL MANUFACTURING

  • 10.1. Labor Cost in Manufacturing Stem Cells
  • 10.2. Cost of Stem Cell Manufacture in a Partially-Automated Facility
  • 10.3. Cost of Stem Cell Manufacture in a Fully-Automatic Facility

11. STEM CELL RESEARCH PRODUCTS: MARKET ANALYSIS

  • 11.1. Global Market for Flow Cytometry Systems used in Cell Culture Studies
    • 11.1.1. Flow Cytometry Market Share by Company
  • 11.2. Global Market for Stem Cell Research Antibodies
    • 11.2.1. Stem Cell Research Antibodies Market Share by Company
  • 11.3. Market for Stem Cell Assay Products
    • 11.3.1. Global Market for Stem Cell Assays by Product Segments
  • 11.4. Global Market for Stem Cell Culture Media
    • 11.4.1. Stem Cell Culture Media Market Share by Company
  • 11.5. Global Market for Recombinant Cell Culture Supplements
  • 11.6. Global Market for Stem Cell Cryopreservation Products
    • 11.6.1. Market Share of Cryopreservation Products by Type
  • 11.7. Market for Single-Use Bioreactors in Stem Cell Culture
    • 11.7.1. Market for Single-Use Bioreactors in Stem Cell Culture by Product Segment
    • 11.7.2. Single-Use Bioreactor Market Share by Company
  • 11.7.3. Massive Investments in Single-Use Bioreactors
  • 11.8. Global Market for Microcarriers used in Cell Culture
  • 11.9. Market for Induced Pluripotent Stem Cells
    • 11.9.1. Toxicology Assays using iPSCs
  • 11.10. Market for Human Mesenchymal Stem Cells (hMSCs)
  • 11.11. Global Market for Embryonic Stem Cells
  • 11.12. Global Market for Stem Cells
  • 11.13. Global Market for Stem Cell Research Products
    • 11.13.1. Leaders in Consumables and Instruments used in Stem Cell Research

12. COMPANY PROFILES

  • 12.1. 3D Biotek LLC
    • 12.1.1. Products
  • 12.2. Abbexa Ltd.
    • 12.2.1. Products
  • 12.3. ABclonal
    • 12.3.1. Products
  • 12.4. Abeomics Inc.
    • 12.4.1. Products
    • 12.4.2. Services
  • 12.5. Abnova
    • 12.5.1. Products
  • 12.6. Absolute Antibody Ltd.
    • 12.6.1. Products
  • 12.7. Agilent Technologies Inc.
    • 12.7.1. Products
  • 12.8. Alomone Labs Ltd.
    • 12.8.1. Products
  • 12.9. AmProtein - China Inc.
    • 12.9.1. Products
  • 12.10. Antigenix America Inc.
    • 12.10.1. Products
  • 12.11. Apceth Biopharma GmbH
    • 12.12.1. Cell Types Offered
    • 12.12.2. Cell Banking & Formulation
  • 12.13. Applikon Biotechnology BV
    • 12.13.1. Products
  • 12.14. AS ONE INTERNATIONAL, INC.
  • 12.15. Assaypro
    • 12.15.1. Products
  • 12.16. ATCC
    • 12.16.1. Products
  • 12.17. Athersys, Inc.
    • 12.17.1. Multistem
  • 12.18. Atlas Antibodies AB
    • 12.18.1. Products
  • 12.19. ATVIO Biotech, Ltd.
    • 12.19.1. Services
  • 12.20. Aviva Systems Biology Corp.
    • 12.20.1. Products
  • 12.21. Becton, Dickinson and Company
    • 12.21.1. Offerings
  • 12.22. Bio Basic
    • 12.22.1. Products & Services
  • 12.23. BioIVT
    • 12.23.1. Products
    • 12.23.2. Services
  • 12.24. BioLegend
    • 12.24.1. Products
  • 12.25. BioLife Solutions Inc.
    • 12.25.1. Products
      • 12.25.1.1. CryoStor
      • 12.25.1.2. HypoThermosol
      • 12.25.1.3. BloodStor
      • 12.25.1.4. Cell Thawing Media
      • 12.25.1.5. ThawSTAR Products
  • 12.26. Bio-Rad Laboratories, Inc.
    • 12.26.1. Products
  • 12.27. Biorbyt Ltd.
    • 12.27.1. Products
  • 12.28. BioSperix Ltd.
    • 12.28.1. Products
  • 12.29. Bioss Antibodies Inc
    • 12.29.1. Products
  • 12.30. BioVendor - Laboratorni Medicina A.S
    • 12.30.1. Products & Services
  • 12.31. BioVision Inc.
    • 12.31.1. Products
  • 12.32. Bio X Cell
    • 12.32.1. Products
  • 12.33. Bon Opus Biosciences
  • 12.33.1. Products
  • 12.34. BosterBio
  • 12.34.1. Products
  • 12.34.2. Services
  • 12.35. CEDARLANE
  • 12.35.1. Products
  • 12.36. Cell Culture Technologies LLC
  • 12.36.1. Products
  • 12.36.2. Platforms
  • 12.37. Cellexus Ltd.
  • 12.37.1. CellMaker Bioreactors
  • 12.38. Cell Microsystems Inc.
  • 12.38.1. Products
  • 12.39. Cell Signaling Technology Inc.
  • 12.39.1. Products
  • 12.40. Celltainer Biotech
  • 12.40.1. Products
  • 12.41. ChromoTek GmbH
  • 12.41.1. Products
  • 12.42. Cognate BioServices Inc.
  • 12.42.1. Services
  • 12.43. Corning Life Sciences
  • 12.43.1. Products
  • 12.44. CUSABIO Technology LLC
  • 12.44.1. Products
  • 12.45. Cygnus Technologies
  • 12.45.1. Products
  • 12.46. Diagenode SA
  • 12.46.1. Products
  • 12.47. DWK Life Sciences
  • 12.47.1. Cell Culture Products
  • 12.48. EMD Millipore Corp.
  • 12.48.1. Services
  • 12.49. enQuire BioReagents
  • 12.49.1. Products
  • 12.50. Enzo Lifesciences Inc.
  • 12.50.1. Products
  • 12.51. EpiGentek Group Inc.
  • 12.51.1. Products
  • 12.52. Eppendorf AG
  • 12.52.1. Products
  • 12.53. Eurogentec, S.A.
  • 12.53.1. Products
  • 12.54. EXBIO Praha a.s
  • 12.54.1. Products
  • 12.55. FabGennix International Inc.
  • 12.55.1. Products
  • 12.56. Fitzgerald Industries International
  • 12.56.1. Products
  • 12.57. GE Healthcare Bio-Sciences
  • 12.57.1. Products
  • 12.58. GeneTex Inc.
  • 12.58.1. Products
  • 12.59. GenScript
  • 12.59.1. Products
  • 12.60. Greiner Bio-One International GmbH
  • 12.60.1. Products
  • 12.61. HemaCare Corporation
  • 12.61.1. Products
  • 12.62. HiMedia Laboratories
  • 12.62.1. Products
  • 12.63. HuaBio
  • 12.63.1. Products
  • 12.63.2. Services
  • 12.64. Hycult Biotech
  • 12.64.1. Products
  • 12.65. HyTest Ltd.
  • 12.65.1. Products
  • 12.66. ImmuQuest Ltd.
  • 12.66.1. Products
  • 12.67. InSphero AG
  • 12.67.1. Product
  • 12.67.1.1. 3D InSight Microtissue
  • 12.68. Invent Biotechnologies Inc.
  • 12.68.1. Products
  • 12.68.1.1. Minute Kits
  • 12.69. InvivoGen
  • 12.69.1. Products
  • 12.70. Irvine Scientific, Inc. (FUJIFILM Irvine Scientific, Inc.)
  • 12.70.1. Products
  • 12.71. iXCells Biotechnologies
  • 12.71.1. Products
  • 12.71.1.1. iPSCs/ESCs
  • 12.71.1.2. iPSC-Derived Cells
  • 12.71.1.3. Human Primary Cells
  • 12.71.1.4. Cell Media & Reagents
  • 12.72. Kerafast, Inc.
  • 12.72.1. Products
  • 12.72.1.1. Antibodies & Secondary Detection Reagents
  • 12.72.1.2. Buffers & Chemicals
  • 12.72.1.3. Cell Culture & Transfection Reagents
  • 12.72.1.4. Cell & Tissue Samples
  • 12.73. LifeSpan BioSciences Inc.
  • 12.73.1. Antibodies
  • 12.74. Lonza AG
  • 12.74.1. Products & Services
  • 12.75. Maine Biotechnology Services (BBI Group)
  • 12.75.1. Services
  • 12.76. MaSTherCell S.A.
  • 12.76.1. Services
  • 12.77. MBL International
  • 12.77.1. Products
  • 12.78. MD Biosciences (Bioproducts Division)
  • 12.78.1. Products
  • 12.79. Miltenyi Biotec GmbH
  • 12.79.1. Products
  • 12.80. Minerva Biotechnologies Corporation
  • 12.81. Monash Antibody Technologies Facility (MATF)
  • 12.81.1. Services
  • 12.82. MP Biomedicals LLC
  • 12.82.1. Products
  • 12.83. MyBioSource Inc.
  • 12.83.1. Products
  • 12.84. Ncardia AG
  • 12.84.1. Solutions Offered
  • 12.85. New England Biolabs
  • 12.85.1. Products
  • 12.86. Novasep Holding SAS
  • 12.86.1. Services
  • 12.87. NovaTeinBio
  • 12.87.1. Products
  • 12.88. Novus Biologicals
  • 12.88.1. Products
  • 12.89. NSJ Bioreagents
  • 12.89.1. Products
  • 12.90. Octane
  • 12.90.1. Cocoon
  • 12.91. PBS Biotech Inc.
  • 12.91.1. Products
  • 12.92. PROGEN
  • 12.92.1. Products
  • 12.93. PromoCell GmbH
  • 12.93.1. Products & Services
  • 12.94. ProSci Inc.
  • 12.94.1. Products
  • 12.94.2. Services
  • 12.95. Proteintech Group Inc.
  • 12.95.1. Products
  • 12.96. ProteoGenix
  • 12.96.1. Products & Services
  • 12.97. QED Bioscience Inc.
  • 12.97.1. Products
  • 12.98. Ray Biotech
  • 12.98.1. Products
  • 12.99. Rev MAb Biosciences
  • 12.99.1. Products
  • 12.100. Reddot Biotech Inc
  • 12.100.1. Products
  • 12.101. R & D Systems
  • 12.101.1. Products
  • 12.102. REPROCELL Inc.
  • 12.102.1. Products
  • 12.102.2. Services
  • 12.103. RoosterBio, Inc.
  • 12.103.1. Products
  • 12.104. RoslinCT
  • 12.104.1. Products
  • 12.105. SAFC Biosciences Inc.
  • 12.105.1. Products
  • 12.106. Santa Cruz Biotechnology Inc.
  • 12.106.1. Products
  • 12.107. Sartorius AG
  • 12.107.1. Products
  • 12.108. ScienCell Research Laboratories
  • 12.108.1. Products
  • 12.108.1.1. Primary Cells
  • 12.108.1.2. Cell Culture Media
  • 12.108.1.3. Stem Cells
  • 12.108.1.4. Other Products
  • 12.109. Sigma-Aldrich Corp.
  • 12.109.1. Products
  • 12.110. Signalway Antibody LLC
  • 12.110.1. Products
  • 12.111. Sino Biological Inc.
  • 12.111.1. Antibodies
  • 12.112. Shanghai Korain Biotech Co., Ltd.
  • 12.112.1. Products
  • 12.113. SouthernBiotech
  • 12.113.1. Products
  • 12.114. StemBioSys, Inc.
  • 12.114.1. CELLvo Matrix
  • 12.114.2. CELLvo Cells
  • 12.115. STEMCELL Technologies.
  • 12.115.1. Products
  • 12.115.1.1. Cell Culture Media and Supplements
  • 12.115.1.2. Cell Isolation Products
  • 12.115.1.3. Primary and Cultured Cells
  • 12.115.1.4. Cell Storage Media
  • 12.116. Synaptic Systems GmbH
  • 12.116.1. Products
  • 12.117. Synthecon Inc.
  • 12.117.1. Products
  • 12.117.1.1. 3D Cell Culture Bioreactors - Rotary Cell Culture
  • 12.118. Takara Bio Inc.
  • 12.118.1. Products
  • 12.119. Terumo BCT Inc.
  • 12.119.1. Products & Services
  • 12.120. Thermo Fisher Scientific Inc
  • 12.120.1. Products
  • 12.121. United States Biological
  • 12.121.1. Products
  • 12.122. Vitrolife AB
  • 12.122.1. Products
  • 12.123. VWR International LLC
  • 12.123.1. Products
  • 12.124. Wuxi Donglin Sci & Tech Development Co. Ltd.
  • 12.124.1. Products
  • 12.125. Xcellerex (GE Healthcare)
  • 12.125.1. Products
  • 12.126. YposKesi, SAS (Genethon)
  • 12.126.1. Products
  • 12.127. Zen-Bio, Inc.
  • 12.127.1. Products
  • 12.128. Zellwerk GmbH
  • 12.128.1. Z RP Technology Implant Moldings

INDEX OF FIGURES

  • Figure 2.1: Research Areas Using Stem Cells
  • Figure 2.2: Species Sources of Cells for Stem Cell Research
  • Figure 2.3: Disease Areas using Stem Cells for Research/Drug Discovery
  • Figure 10.1: Categories of Expenditure in Stem Cell Manufacturing
  • Figure 10.2: The Impact of Head Count on Labor Cost
  • Figure 10.3: Cost of Stem Cell Manufacture in a Partially-Automated Facility
  • Figure 10.4: Cost of Stem Cell Manufacture in a Fully-Automatic Facility
  • Figure 11.1: Global Market for Flow Cytometry Systems used in Cell Culture, 2019-2026
  • Figure 11.2: Flow Cytometry Market Share by Company
  • Figure 11.3: Global Market for Stem Cell Research Antibodies, 2019-2026
  • Figure 11.4: Stem Cell Research Antibodies Market Share by Company
  • Figure 11.5: Global Market for Stem Cell Assays by Geography, 2019-2026
  • Figure 11.6: Global Market for Stem Cell Assays by Product Segments
  • Figure 11.7: Global Market for Stem Cell Media by Geography, 2019-2026
  • Figure 11.8: Stem Cell Culture Media Market Share by Company
  • Figure 11.9: Global Market for Recombinant Cell Culture Supplements, 2019-2026
  • Figure 11.10: Global Market for Stem Cell Cryopreservation Products, 2019-2026
  • Figure 11.11: Market Share of Cryopreservation Products by Type, 2019
  • Figure 11.12: Market for SUBs in Stem Cell Culture by Geography, 2019-2026
  • Figure 11.13: Market for Single-Use Bioreactors in Stem Cell Culture by Product Segment
  • Figure 11.14: Single-Use Bioreactor Market Share by Company
  • Figure 11.15: Global Market for Microcarriers by Geography, 2019-2026
  • Figure 11.16: Global Market for Induced Pluripotent Stem Cells by Geography, 2019-2026
  • Figure 11.17: Relative Use of iPSC-Derived Cell Types in Toxicology Assays
  • Figure 11.18: Global Market for Mesenchymal Stem Cells by Geography, 2019-2026
  • Figure 11.19: Global Market for Embryonic Stem Cells by Geography, 2019-2026
  • Figure 11.20: Global Market for Stem Cells by Geography, 2019-2026
  • Figure 11.21: Global Market for Stem Cell Research Products by Type, 2019-2026
  • Figure 11.22: Major Suppliers of Consumables and Instruments in Stem Cell Research

INDEX OF TABLES

  • Table 3.1: Examples of Embryonic Stem Cell Markers and Antibody Suppliers
  • Table 3.2: Examples of Hematopoietic Stem Cell Markers and Antibody Suppliers
  • Table 3.3: Examples of Cancer Stem Cell Markers and Antibody Suppliers
  • Table 3.4: Examples of Osteoprogenitor Cell Markers and Antibody Suppliers
  • Table 3.5: Examples of Neural Stem Cell Markers and Antibody Suppliers
  • Table 3.6: Examples of Mesenchymal Stem Cell Markers and Suppliers of Antibodies
  • Table 3.7: Examples of Skin Stem Cell Markers and Antibody Suppliers
  • Table 4.1: Commercially Available Stem Cell Isolation Kits and Suppliers
  • Table 4.2: Commercially Available Flow Cytometry Systems
  • Table 5.1: Commercially Available Primary Antibodies
  • Table 5.2: Commercially Available Secondary Antibodies
  • Table 5.3: Commercially Available Recombinant Antibodies
  • Table 5.4: Commercially Available Trial Size Antibodies
  • Table 5.5: Commercially Available Apoptosis Antibodies
  • Table 5.6: Commercially Available Epitope Tag Antibodies
  • Table 5.7: Commercially Available Isotype Control Antibodies
  • Table 5.8: Pluripotent Stem Cell Markers Antibody Products and Suppliers
  • Table 5.9: Mesenchymal Stem Cell Markers Antibody Products
  • Table 5.10: Hematopoietic Stem Cell Markers Antibody Products
  • Table 5.11: Neural Stem Cell Marker Antibodies
  • Table 5.12: Cancer Stem Cell Marker Antibodies
  • Table 5.13: Companies Providing Antibody Production and Development Services
  • Table 5.14: Companies Providing Monoclonal Antibody Production Services
  • Table 5.15: Companies Offering Polyclonal Antibody Production Services
  • Table 5.16: Companies Offering Antibody Purification Services
  • Table 5.17: Companies Offering Antibody Conjugation and Labeling Services
  • Table 5.18: Companies Providing Hybridoma Services
  • Table 5.19: Companies Offering Recombinant Antibody Production Services
  • Table 5.20: Commercially Available Stem Cell Factor ELISA Kits and Suppliers
  • Table 6.1: Types of Natural and Artificial Media
  • Table 6.2: Cell Lines and Choice of Culture Media
  • Table 6.3: Recommended Media for Primary Cell Culture
  • Table 6.4: Companies Offering Stem Cell Culture Media
  • Table 6.5: Examples of Methylcellulose Media
  • Table 6.6: Commercially Available Stem Cell Differentiation Media
  • Table 6.7: Commercially Available Stem Cell Expansion Media
  • Table 6.8: Commercially Available Embryonic Stem Cell Media
  • Table 6.9: Commercially Available Hematopoietic Stem Cell Media
  • Table 6.10: Commercially Available Mesenchymal Stem Cell Media
  • Table 6.11: Commercially Available Neural Stem Cell Media
  • Table 6.12: Components of Media Supplements
  • Table 6.13: Commercially Available Cell Culture Supplements and Vendors
  • Table 6.14: Examples of Cell Freezing Media
  • Table 7.1: Bioreactors used for Stem Cell Expansion
  • Table 7.2: Pros and Cons of Fixed Bioreactors
  • Table 7.3: Pros and Cons of Single Use Bioreactors
  • Table 7.4: Commercially Available Liter- and Cubic Meter-Scale SUBs
  • Table 7.5: Main Features of Commercial Bioreactors
  • Table 7.6: Main Differences between Single-Use and Multi-Use Bioreactors
  • Table 7.7: Microcarriers used in Bioreactors
  • Table 8.1: Examples of Commercially Available Stem Cell Lines
  • Table 9.1: Select Institutional Manufacturing Facilities for Stem Cell Manufacture
  • Table 9.2: Select CMOs and Their Services in Stem Cell Manufacturing
  • Table 9.3: Select Cell Manufacturing Solutions
  • Table 9.4: Select Closed Manufacturing Systems
  • Table 10.1: Categories of Expenditure in Stem Cell Manufacturing
  • Table 10.2: The Impact of Head Count on Labor Cost
  • Table 10.3: Cost of Stem Cell Manufacture in a Partially-Automated Facility
  • Table 10.4: Cost of Stem Cell Manufacture in a Fully-Automatic Facility
  • Table 11.1: Global Market for Flow Cytometry Systems used in Cell Culture, 2019-2026
  • Table 11.2: Global Market for Stem Cell Research Antibodies, 2019-2026
  • Table 11.3: Global Market for Stem Cell Assays by Geography, 2019-2026
  • Table 11.4: Global Market for Stem Cell Media by Geography, 2019-2026
  • Table 11.5: Global Market for Recombinant Cell Culture Supplements, 2019-2026
  • Table 11.6: Market for Stem Cell Cryopreservation Products by Geography, 2019-2026
  • Table 11.7: Global Market for SUBs in Stem Cell Culture by Geography, 2019-2026
  • Table 11.8: Global Market for Microcarriers by Geography, 2019-2026
  • Table 11.9: Global Market for iPSCs by Geography, 2019-2026
  • Table 11.10: Global Market for Mesenchymal Stem Cells by Geography, 2019-2026
  • Table 11.11: Global Market for Embryonic Stem Cells by Geography, 2019-2026
  • Table 11.12: Global Market for Stem Cells by Cell Type, 2019-2026
  • Table 11.13: Global Market for Stem Cell Research Products, 2019-2026
  • Table 11.14: Major Suppliers of Consumables and Instruments in Stem Cell Research
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.